In the wake of the novel coronavirus outbreak, the biopharmaceutical company with the highest market capitalization change of over nine billion dollars - in the given time range - was Gilead Sciences as they started phase three trials of their antiviral drug remdesivir for the treatment of COVID-19. This statistic depicts the market capitalization changes of select biopharmaceutical companies which are involved in R&D on the novel coronavirus to find treatments or vaccines, in regards to the period from January 20 to February 25, 2020.
Market capitalization changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Vantage. (February 27, 2020). Market capitalization changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 (in million U.S. dollars) [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1103618/market-cap-changes-in-biopharma-companies-involved-in-covid-19-research/
Vantage. "Market capitalization changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 (in million U.S. dollars)." Chart. February 27, 2020. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1103618/market-cap-changes-in-biopharma-companies-involved-in-covid-19-research/
Vantage. (2020). Market capitalization changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 (in million U.S. dollars). Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1103618/market-cap-changes-in-biopharma-companies-involved-in-covid-19-research/
Vantage. "Market Capitalization Changes of Select Biopharmaceutical Companies Involved in Coronavirus (Covid-19) Research from January 20 to February 25, 2020 (in Million U.S. Dollars)." Statista, Statista Inc., 27 Feb 2020, https://www.statista.com/statistics/1103618/market-cap-changes-in-biopharma-companies-involved-in-covid-19-research/
Vantage, Market capitalization changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1103618/market-cap-changes-in-biopharma-companies-involved-in-covid-19-research/ (last visited December 21, 2024)
Market capitalization changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 (in million U.S. dollars) [Graph], Vantage, February 27, 2020. [Online]. Available: https://www.statista.com/statistics/1103618/market-cap-changes-in-biopharma-companies-involved-in-covid-19-research/
